James E. Audia

James E. Audia

Director/Board Member chez Ribon Therapeutics, Inc.

68 ans
Health Technology
Consumer Services
Commercial Services

Profil

James E.
Audia
is currently the Director at Ribon Therapeutics, Inc. and a Member at Alzheimer's Association.
Previously, he served as the Independent Director at Constellation Pharmaceuticals, Inc. from 2011 to 2021.
He was also the Executive Director at Chicago Biomedical Consortium from 2017 to 2019.
Additionally, he held the position of Head-Chemistry at Karuna Therapeutics, Inc. from 2019 to 2024.
Dr. Audia obtained his doctorate degree from Yale University and the University of South Carolina.

Postes actifs de James E. Audia

SociétésPosteDébut
Director/Board Member 01/04/2018
Corporate Officer/Principal 01/01/2020
Tous les postes actifs de James E. Audia

Anciens postes connus de James E. Audia

SociétésPosteFin
KARA THER Corporate Officer/Principal 18/03/2024
CONSTELLATION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/07/2017
Chicago Biomedical Consortium Director/Board Member 01/10/2019
Voir l'expérience en détail de James E. Audia

Formation de James E. Audia

Yale University Doctorate Degree
University of South Carolina Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James E. Audia

Relations

100 +

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées5

Commercial Services

Health Technology

Health Technology

Health Technology

Chicago Biomedical Consortium

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. James E. Audia